2021 New Treatment Accelerator Grant Recipients
The New Treatment Accelerator Grants fund projects at any stage (preclinical to clinical) that will significantly accelerate treatments to pancreatic cancer patients,
and grow capacity in pancreatic cancer research in Australia. Grant applications were assessed by our international Scientific Advisory Panel comprised of international and national experts in the field.
The New Treatment Accelerator Grants fund projects at any stage (preclinical to clinical) that will significantly accelerate treatments to pancreatic cancer patients,
and grow capacity in pancreatic cancer research in Australia. Grant applications were assessed by our international Scientific Advisory Panel comprised of international and national experts in the field.
Accelerator Grants
Spatial Transcriptomics a Pathway to Dissecting Barriers to Effective Treatment in Pancreatic Cancer
3D Human Tumour Explant Culture to Inform Precision Medicine in Pancreatic Cancer
Repurposing FDA/TGA-approved PCSK9 inhibitor evolocumab to enhance immunotherapy outcomes in pancreatic cancer
